Skip to content

A Clinical Efficacy Study of Intermittent Theta Burst Stimulation (iTBS) in Adolescent Patients with Depression During the Acute Phase

A Clinical Efficacy Study of Intermittent Theta Burst Stimulation (iTBS) in Adolescent Patients with Depression During the Acute Phase

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101152
Enrollment
Unknown
Registered
2025-04-21
Start date
2024-09-13
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

control group:sham intermittent theta burst stimulation (iTBS) treatment
Experimental Group:Intermittent theta burst stimulation (iTBS) treatment

Sponsors

Zhong Shan Third Peoples' Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for depressive episode (F32.1, F32.2) in the International Classification of Diseases, 10th Revision (ICD-10); 2. Be between 14 and 18 years old, regardless of gender; 3.Be in the acute phase of a depressive episode; 4. Have a HAMD-24 score of >=20, and a score on item 4 or 5 of the Beck Scale for Suicide Ideation (BSI) of >0; 5. Have received at least primary school education or above; 6. Understand the purpose and content of the study, and be willing to cooperate in completing it; 7. The patient and guardian have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Have a history of diseases affecting the central nervous system or severe physical illnesses; 2.Have a risk of epileptic seizures or a family history of epilepsy, such as abnormal electroencephalograms (EEGs) or abnormal brain magnetic resonance imaging (MRI) results; 3. Have a history of abuse or dependence on psychoactive substances; 4. Have absolute contraindications for rTMS, that is, metallic implants in the cranial cavity; 5. Have received rTMS, electroconvulsive therapy, or other electrical or magnetic stimulation treatments within the past month.

Design outcomes

Primary

MeasureTime frame
24-item Hamilton Depression Rating Scale;

Secondary

MeasureTime frame
Hamilton Anxiety Scale;Beck Scale for Suicide Ideation;Ottawa Self-Injury Inventory;Stroop Word-Color Interference test;Wisconsin card sorting test;Event-related potentials P300;Record of adverse reactions to TMS treatment;

Countries

China

Contacts

Public ContactZhang jie

Zhong Shan Third Peoples' Hospital

13790875171@163.com+86 760 85529821

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 31, 2026